Furthermore, BIRC5 was expressed over two-fold higher in estrogen receptor-negative (ER−) breast cancers compared to estrogen receptor-positive (ER+) breast cancers (Fig. 1D, p = 9e-46). Here, ESR1 is linked to breast cancer.